Morphological diversity of cancer cells predicts prognosis across tumor types
JNCI: Journal of the National Cancer Institute · 05.04.2024 · 116 (4) · 555-564
DOI: 10.1093/jnci/djad243 ↗Kurz gefasst
Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, online erschienen am 20.11.2023. Verfasst von Rasoul Sali und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDCR NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Background
Intratumor heterogeneity drives disease progression and treatment resistance, which can lead to poor patient outcomes. Here, we present a computational approach for quantification of cancer cell diversity in routine hematoxylin-eosin–stained histopathology images.
Methods
We analyzed publicly available digitized whole-slide hematoxylin-eosin images for 2000 patients. Four tumor types were included: lung, head and neck, colon, and rectal cancers, representing major histology subtypes (adenocarcinomas and squamous cell carcinomas). We performed single-cell analysis on hematoxylin-eosin images and trained a deep convolutional autoencoder to automatically learn feature representations of individual cancer nuclei. We then computed features of intranuclear variability and internuclear diversity to quantify tumor heterogeneity. Finally, we used these features to build a machine-learning model to predict patient prognosis.
Results
A total of 68 million cancer cells were segmented and analyzed for nuclear image features. We discovered multiple morphological subtypes of cancer cells (range = 15-20) that co-exist within the same tumor, each with distinct phenotypic characteristics. Moreover, we showed that a higher morphological diversity is associated with chromosome instability and genomic aneuploidy. A machine-learning model based on morphological diversity demonstrated independent prognostic values across tumor types (hazard ratio range = 1.62-3.23, P < .035) in validation cohorts and further improved prognostication when combined with clinical risk factors.
Conclusions
Our study provides a practical approach for quantifying intratumor heterogeneity based on routine histopathology images. The cancer cell diversity score can be used to refine risk stratification and inform personalized treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA.
- Department of Radiation Oncology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
- Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
ORCID-Profile: Rasoul Sali, Ruijiang Li
Förderung
- NCI NIH HHS
- NIDCR NIH HHS
- National Institutes of Health
- National Cancer Institute
- National Institute of Dental and Craniofacial Research
Zitieren
APA
Sali, R., Jiang, Y., Attaranzadeh, A., Holmes, B., & Li, R. (2024). Morphological diversity of cancer cells predicts prognosis across tumor types. JNCI: Journal of the National Cancer Institute, 116(4), 555-564. https://doi.org/10.1093/jnci/djad243
Vancouver
Sali R, Jiang Y, Attaranzadeh A, Holmes B, Li R. Morphological diversity of cancer cells predicts prognosis across tumor types. JNCI: Journal of the National Cancer Institute. 2024;116(4):555-564. doi:10.1093/jnci/djad243
BibTeX
@article{Sali2024,
author = {Sali, Rasoul and Jiang, Yuming and Attaranzadeh, Armin and Holmes, Brittany and Li, Ruijiang},
title = {Morphological diversity of cancer cells predicts prognosis across tumor types},
journal = {JNCI: Journal of the National Cancer Institute},
year = {2024},
volume = {116},
number = {4},
pages = {555--564},
doi = {10.1093/jnci/djad243}
}
EUVIMED